226 related articles for article (PubMed ID: 9039294)
1. Increased levels of type I and III collagen and hyaluronan in scleroderma skin.
Søndergaard K; Heickendorff L; Risteli L; Risteli J; Zachariae H; Stengaard-Pedersen K; Deleuran B
Br J Dermatol; 1997 Jan; 136(1):47-53. PubMed ID: 9039294
[TBL] [Abstract][Full Text] [Related]
2. The use of serologic markers for collagen synthesis and degradation in systemic sclerosis.
Heickendorff L; Zachariae H; Bjerring P; Halkier-Sørensen L; Søndergaard K
J Am Acad Dermatol; 1995 Apr; 32(4):584-8. PubMed ID: 7896946
[TBL] [Abstract][Full Text] [Related]
3. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
Zachariae H; Halkier-Sørensen L; Heickendorff L
Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
[TBL] [Abstract][Full Text] [Related]
4. Type I and III procollagens in CAPD: markers of peritoneal fibrosis.
Joffe P; Jensen LT
Adv Perit Dial; 1991; 7():158-60. PubMed ID: 1680415
[TBL] [Abstract][Full Text] [Related]
5. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
[TBL] [Abstract][Full Text] [Related]
6. Effect of jaundice and its resolution on wound re-epithelization, skin collagen synthesis, and serum collagen propeptide levels in patients with neoplastic pancreaticobiliary obstruction.
Koivukangas V; Oikarinen A; Risteli J; Haukipuro K
J Surg Res; 2005 Apr; 124(2):237-43. PubMed ID: 15820253
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronate in suction blisters from patients with scleroderma and various skin disorders.
Juhlin L; Tengblad A; Ortonne JP; Lacour JP
Acta Derm Venereol; 1986; 66(5):409-13. PubMed ID: 2431578
[TBL] [Abstract][Full Text] [Related]
8. Collagen synthesis in human skin in vivo: modulation by aging, ultraviolet B irradiation and localization.
Autio P; Risteli J; Haukipuro K; Risteli L; Oikarinen A
Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):212-6. PubMed ID: 7880761
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis.
Milman N; Kristensen MS; Bentsen K; Grode G; Frederiksen J
Sarcoidosis; 1995 Mar; 12(1):38-41. PubMed ID: 7617974
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of extracellular matrix components: novel markers of metabolic control and hepatic pathology in glycogen storage disease?
Calçado A; Trivedi P; Portmann B; Mowat AP
J Pediatr Gastroenterol Nutr; 1991 Jul; 13(1):1-9. PubMed ID: 1919939
[TBL] [Abstract][Full Text] [Related]
11. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen in children with growth retardation.
Cinaz P; Hasanoglu E; Gökçora N; Dogukan S; Demir A
Mater Med Pol; 1994; 26(2):55-8. PubMed ID: 7745984
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced changes in skin type I and III collagen synthesis during and after conventionally fractionated radiotherapy.
Keskikuru R; Jukkola A; Nuutinen J; Kataja V; Risteli J; Autio P; Lahtinen T
Radiother Oncol; 2004 Mar; 70(3):243-8. PubMed ID: 15064008
[TBL] [Abstract][Full Text] [Related]
14. Plasma and tissue levels of collagen types I and III markers in patients with abdominal aortic aneurysms.
Treska V; Topolcan O
Int Angiol; 2000 Mar; 19(1):64-8. PubMed ID: 10853688
[TBL] [Abstract][Full Text] [Related]
15. Effect of topical tretinoin on non-sun-exposed human skin connective tissue: induction of tenascin but no major effect on collagen metabolism.
Haapasaari KM; Kallioinen M; Tasanen K; Sutinen M; Annala AP; Risteli J; Oikarinen A
Br J Dermatol; 1997 Jun; 136(6):891-900. PubMed ID: 9217822
[TBL] [Abstract][Full Text] [Related]
16. [Type I and III procollagen in patients with abdominal aorta aneurysms].
Treska V; Topolcan O; Kocová J; Pecen L; Tonar Z
Cas Lek Cesk; 1999 Mar; 138(5):142-6. PubMed ID: 10376397
[TBL] [Abstract][Full Text] [Related]
17. Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.
Hørslev-Petersen K; Ammitzbøll T; Engström-Laurent A; Bentsen K; Junker P; Asboe-Hansen G; Lorenzen I
J Rheumatol; 1988 Mar; 15(3):460-7. PubMed ID: 3259985
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
Scheja A; Akesson A; Hørslev-Petersen K
Scand J Rheumatol; 1992; 21(1):5-9. PubMed ID: 1570489
[TBL] [Abstract][Full Text] [Related]
19. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
Lammi L; Kinnula V; Lähde S; Risteli J; Pääkkö P; Lakari E; Ryhänen L
Eur Respir J; 1997 Dec; 10(12):2725-30. PubMed ID: 9493651
[TBL] [Abstract][Full Text] [Related]
20. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.
Meduri GU; Tolley EA; Chinn A; Stentz F; Postlethwaite A
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
